Importantly, IFN treatment alone fails to induce leukemia rejection, emphasizing a ppp-RNA specific effect that initiates an adaptive immune response in a multistep process in which type I IFN plays a critical part [36]. The gene discussed is IFNA1; the disease is leukemia.